Skip to main content
OpenTrials
Completed

NCT Number: NCT03427762

Compare the Effects of Agility and Cycling Exercise Training on Mobility and Balance in PD and Healthy Old Adults

The purpose of the study is to compare the effectiveness and specificity of agility and cycling exercise training on balance and mobility outcomes in PD and age and gender matched healthy controls. The hypothesis is that due to being profoundly deconditioned, agility and cycling will be similarly effective in PD but agility will be more effective then cycling in healthy old adults, in improving mobility and balance.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Condition Disease Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinson Disease Parkinsonian Disorders Pathologic Processes Pathological Conditions, Signs and Symptoms Synucleinopathies

Age range

55 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

József Tollár

Kaposvár, Somogy County, 7400, Hungary

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • family doctor should be qualified as healthy.
  • older adults had to have basic fitness
  • weekly movement of at least 3 hours

Exclusion criteria

  • Severe heart problems
  • severe demeanor
  • alcoholism
  • drug problems

Treatment and study plan

rehabilitation

Other

Healthy cycling group: The group participates in 5 weeks of intensive cycling therapy.

Healthy xbox group: The group participates in 5 week intensive xbox therapy Healthy controll group: The group does not take any kind of therapy. PD group: We have already analyzed the results of our group, and we will compare their results with the results of healthy groups.

Other names: Healthy cycling group, Healthy xbox group, PD group

Primary outcomes

  1. Postural instability

    Time frame: 5 weeks

    Body sway (mm) (Posturography test)

  2. quality of life

    Time frame: 5 weeks

    EQ-5D (EQ-5D was first introduced in 1990 by the EuroQol Group, The EQ-5D questionnaire is made up for two components; health state description and evaluation)

  3. balance test

    Time frame: 5 weeks

    Berg Balance test (The Berg Balance Scale (BBS) was developed to measure balance among older people with impairment in balance function by assessing the performance of functional tasks, 41-56 = low fall risk, 21-40 = medium fall risk, 0 -20 = high fall risk )

  4. mobility test

    Time frame: 5 weeks

    Six minutes walk test (6MWT) (m) (The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes. The individual is allowed to self-pace and rest as needed as they traverse back and forth along a marked walkway)

Secondary outcomes

  1. depression scale

    Time frame: 5 weeks

    Beck Depression scale (The Beck Depression Inventory (BDI) is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression, 0-13: minimal depression, 14-19: mild depression, 20-28: moderate depression, 29-63: severe depression)

Sponsors and collaborators

Lead sponsor

Somogy Megyei Kaposi Mór Teaching Hospital

Other

Collaborators

  • University of Groningen

Registry information

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Feb 9, 2018
Registry last updated
Apr 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.